Investors
Shire Makes Second Ophtha Purchase
Shire pay US$160 million for SARcode Bioscience. Shire recently announced its purchase of privately owned US biotech firm SARcode Bioscience. The acquisition was worth US$160 million and central to the deal is the rights over a new drug in the late stages of development that helps cure dry eye disease.
Fuh Hwa Securities Granted Permit by Taiwanese Financial Regulator
The Taiwanese financial regulator had granted permission for Fuh Hwa Securities Investment Trust to form the yuan denominated mutual fund.
Sherpa Raises US$1.6 Million
Sherpa was able to raise from investors and venture capitalist US$1.6 million for its project ventures.
CDW Preparing for IPO
CDW has filed papers of its IPO with the SEC. CDW Corp had filed documentation with US regulators reporting the raising of US$500 million in its initial public offering.




